|
Jul 30
|
Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
|
|
Jul 30
|
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
|
|
Jul 30
|
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
|
|
Jul 29
|
Company News for Jul 29, 2024
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 29
|
Bristol Myers Squibb reports dip in net income for Q2 2024
|
|
Jul 27
|
Why Wall Street is unfazed by Medicare drug pricing threat
|
|
Jul 27
|
2 High-Yield Dividend Stocks That Could Shine in 2025
|
|
Jul 27
|
Q2 2024 Bristol-Myers Squibb Co Earnings Call
|
|
Jul 26
|
Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win
|
|
Jul 26
|
These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
|
|
Jul 26
|
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
|
|
Jul 26
|
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
|
|
Jul 26
|
Newell Brands, 3M rise; Saia, DexCom fall, Friday, 7/26/2024
|
|
Jul 26
|
Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge
|
|
Jul 26
|
Stocks to Watch Friday: DexCom, 3M, Coinbase, Charter
|
|
Jul 26
|
Bristol Myers Stock Rises Sharply. A Sales Jump for Eliquis Boosts Earnings.
|
|
Jul 26
|
PCE/Core PCE Inflation In Line With Estimates in June
|
|
Jun 24
|
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
|
|
Jun 24
|
BMS expands Krazati’s FDA label to include colorectal cancer
|